Skip to main content
Top
Published in: International Cancer Conference Journal 4/2019

01-10-2019 | Magnetic Resonance Imaging | Case report

Incidental abdominal lymph node metastases from a known breast cancer in resected specimen of invasive pancreatic ductal adenocarcinoma: report of a case

Authors: Tomohiko Taniai, Koichiro Haruki, Michinori Matsumoto, Taro Sakamoto, Hiroaki Shiba, Katsuhiko Yanaga

Published in: International Cancer Conference Journal | Issue 4/2019

Login to get access

Abstract

Breast cancer is known to metastasize to all organs of the body. However, abdominal lymph node metastases from breast cancer are extremely rare. We herein report a resected case of an invasive pancreatic ductal adenocarcinoma (PDAC) in which abdominal lymph node metastases from breast cancer were diagnosed. A 54-year-old woman was pointed out to have a tumor in the pancreatic tail with dilatation of the distal pancreatic duct. She had undergone partial mastectomy for left breast cancer at the age of 51 years and had undergone partial liver resection for liver metastasis in the segment 3/4 6 months earlier. Computed tomography revealed a low-density tumor in the pancreatic tail with dilated distal main pancreatic duct. Magnetic resonance imaging (MRI) exhibited a high-intensity tumor in the pancreatic tail in diffusion-weighted images. With a diagnosis of pancreatic cancer, distal pancreatectomy and splenectomy with lymph nodes dissection was performed. Lymph node metastases along the splenic artery were pathologically similar to PDAC. However, lymph node metastases along the left gastric artery, common hepatic artery, celiac axis, and superior mesenteric artery were pathologically similar to breast cancer. Immunohistochemistry staining of abdominal lymph nodes with GATA-3 was positive, which strongly suggested metastatic breast cancer. Although she received chemotherapy with S-1 for breast cancer and PDAC for 4 months, MRI showed multiple liver metastases derived from breast cancer. Finally, she died 12 months after operation.
Literature
1.
go back to reference Lee YT (1985) Patterns of metastasis and natural courses of breast carcinoma. Cancer Metastasis Rev 4:153–172CrossRefPubMed Lee YT (1985) Patterns of metastasis and natural courses of breast carcinoma. Cancer Metastasis Rev 4:153–172CrossRefPubMed
2.
go back to reference Kleeff J, Korc M, Apte M et al (2016) Pancreatic cancer. Nat Rev Dis Primers 2:16022CrossRef Kleeff J, Korc M, Apte M et al (2016) Pancreatic cancer. Nat Rev Dis Primers 2:16022CrossRef
4.
go back to reference Borst MJ, Ingold JA (1993) Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. Surgery 114(4):637–641PubMed Borst MJ, Ingold JA (1993) Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. Surgery 114(4):637–641PubMed
5.
go back to reference Golse N, Adam R (2017) Liver metastases from breast cancer: what role for surgery? Indications and results. Clin Breast Cancer 17(4):256–265CrossRefPubMed Golse N, Adam R (2017) Liver metastases from breast cancer: what role for surgery? Indications and results. Clin Breast Cancer 17(4):256–265CrossRefPubMed
6.
go back to reference Haagensen CD (1971) Disease of the breast, 2nd edn. Sanders Company, Philadelphia, pp 46–47 Haagensen CD (1971) Disease of the breast, 2nd edn. Sanders Company, Philadelphia, pp 46–47
Metadata
Title
Incidental abdominal lymph node metastases from a known breast cancer in resected specimen of invasive pancreatic ductal adenocarcinoma: report of a case
Authors
Tomohiko Taniai
Koichiro Haruki
Michinori Matsumoto
Taro Sakamoto
Hiroaki Shiba
Katsuhiko Yanaga
Publication date
01-10-2019

Other articles of this Issue 4/2019

International Cancer Conference Journal 4/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine